Prostatic fluid-free insulin-like growth factor-1 in relation to prostate cancer

BJU International

Volumn 88, Issue 9, 2001, Pages 946-949

  Perk, H ^a   Serel, T A ^a,b   Delibas, N ^a   Sutcu R ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY   (Turkey)

Author keywords

IGF 1; Prostate cancer; Prostatic fluid; PSA; Tumour marker

Indexed keywords

SOMATOMEDIN C; TUMOR MARKER;

ADULT; AGE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; MALE; PRIORITY JOURNAL; PROSTATE CARCINOMA; PROSTATE FLUID; PROTEIN BLOOD LEVEL; RADIOIMMUNOASSAY;

ADENOCARCINOMA; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MIDDLE AGED; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS;

EID: 0035701143     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-4096.2001.02438.x     Document Type: Article

References (22)

1. Peptide growth factors in the prostate as mediators of stromal epithelial interaction
2. The role of the IGF-1 receptor in apoptosis
3. Insulin-like growth factor in the kidney
4. Growth hormone treatment in growth retarded children with end stage renal failure: Effect on free/dissociable IGF-1 levels
5. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency
6. Acute metabolic effects and half-lives of intravenously administered insulin-like growth factors I and II in normal and hypophysectomized rats
7. Short-term metabolic effects of recombinant human insulin-like growth factor I in healthy adults
8. Elevated levels of insulin-like growth factor binding protein-2 in the serum of prostate cancer patients
9. Serum insulin-like growth factor-binding protein-2 (IGFBP-2) is increased and IGFBP is decreased in patients with prostate cancer correlation with serum prostate specific antigen
10. Insulin-like growth factor binding protein-2 in patients with prostate carcinoma and benign prostatic hyperplasia
11. Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia
12. Biochemical profiles of prostatic fluid from normal and diseased prostate glands
13. Measurement of serum ferritin by a 2-site immunoradiometric assay
14. The insulin-like growth factor type I receptor stimulates growth and suppresses apoptosis in prostatic stromal cells
15. Identification and molecular characterisation of insuline-like growth factor binding proteins
16. Insulin-like growth factors, IGF receptors and IGF binding proteins in primary culture of prostate epithelial cells
17. Serum insulin-like growth factor-1 is not a useful marker of prostate cancer
18. Serum insulin-like growth factor-1 in 1030 healthy children, adolescents, and adults: Relation to age, sex, stage of puberty, testicular size, and body mass index
19. The ratio between serum levels of insulin-like growth factor (IGF)-1 and the IGF binding proteins (IGFBP-1,2 and 3) decreases with age in healthy adults and is increased in acromegalic patients
20. Epidemiology of insulin-like growth factor-1 in elderly men and women. The Rancho Bernardo study
21. Somatomedin-C levels in growth-impaired children and adolescents with chronic inflammatory bowel disease
22. Radioimmunoassay of serum IGF-1 and IGF-II in patients with chronic liver diseases and hepatocellular carcinoma with or without hypoglycemia